Literature DB >> 3021815

Detection of cytomegalovirus antibody by enzyme immunoassay and lack of evidence for an effect resulting from strain heterogeneity.

S P Adler, M McVoy.   

Abstract

A total of 259 serum samples from random blood donors were assayed by an enzyme immunoassay for antibody to cytomegalovirus (CMV) with antigens prepared from eight genetically unrelated clinical isolates of CMV and the laboratory-adapted strains AD169 and Towne. A total of 144 serum samples were reactive against all 10 strains, and 115 serum samples lacked immunoglobulin against all 10 strains. The results support the continued use of the AD169 strain of human CMV as the reference antigen for CMV serologic testing.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3021815      PMCID： PMC269049          DOI： 10.1128/jcm.24.5.870-872.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  13 in total

1.  Antigenic relatedness of 17 strains of human cytomegalovirus.

Authors:  S L Zablotney; B B Wentworth; E R Alexander
Journal:  Am J Epidemiol       Date:  1978-04       Impact factor: 4.897

2.  The molecular epidemiology of cytomegalovirus transmission among children attending a day care center.

Authors:  S P Adler
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

3.  Detection of cytomegalovirus antibody with latex agglutination.

Authors:  S P Adler; M McVoy; V G Biro; W J Britt; P Hider; D Marshall
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

4.  Cytomegalovirus antigenic heterogeneity can cause false-negative results in indirect hemagglutination and complement fixation antibody assays.

Authors:  R G Faix
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

5.  Patterns of cytomegaloviral complement-fixing antibody activity: a longitudinal study of blood donors.

Authors:  J L Waner; T H Weller; S V Kevy
Journal:  J Infect Dis       Date:  1973-05       Impact factor: 5.226

6.  Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants.

Authors:  S A Plotkin; M L Smiley; H M Friedman; S E Starr; G R Fleisher; C Wlodaver; D C Dafoe; A D Friedman; R A Grossman; C F Barker
Journal:  Lancet       Date:  1984-03-10       Impact factor: 79.321

7.  Sequelae of maternally derived cytomegalovirus infections in premature infants.

Authors:  A S Yeager; P E Palumbo; N Malachowski; R L Ariagno; D K Stevenson
Journal:  J Pediatr       Date:  1983-06       Impact factor: 4.406

8.  Prevention of transfusion-acquired cytomegalovirus infections in newborn infants.

Authors:  A S Yeager; F C Grumet; E B Hafleigh; A M Arvin; J S Bradley; C G Prober
Journal:  J Pediatr       Date:  1981-02       Impact factor: 4.406

9.  Vaccination of pediatric nurses with live attenuated cytomegalovirus.

Authors:  G R Fleisher; S E Starr; H M Friedman; S A Plotkin
Journal:  Am J Dis Child       Date:  1982-04

Review 10.  Transfusion-associated cytomegalovirus infections.

Authors:  S P Adler
Journal:  Rev Infect Dis       Date:  1983 Nov-Dec
View more
  3 in total

1.  Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection.

Authors:  Xiaohong Cui; Benjamin P Meza; Stuart P Adler; Michael A McVoy
Journal:  Vaccine       Date:  2008-08-19       Impact factor: 3.641

2.  Lack of autoantibody production associated with cytomegalovirus infection.

Authors:  Beth C Marshall; Richard A McPherson; Eric Greidinger; Robert Hoffman; Stuart P Adler
Journal:  Arthritis Res       Date:  2002-06-20

Review 3.  Infection with cytomegalovirus is not associated with premature mortality.

Authors:  Stuart P Adler; Al M Best; Beth Marshall; George W Vetrovec
Journal:  Infect Dis Rep       Date:  2011-12-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.